A homozygous CARD9 mutation in a family with susceptibility to fungal infections.

Full Abstract

BACKGROUND: Chronic mucocutaneous candidiasis may be manifested as a primary immunodeficiency characterized by persistent or recurrent infections of the mucosa or the skin with candida species. Most cases are sporadic, but both autosomal dominant inheritance and autosomal recessive inheritance have been described. METHODS: We performed genetic studies in 36 members of a large, consanguineous five-generation family, in which 4 members had recurrent fungal infections and an additional 3 members died during adolescence, 2 after invasive infection of the brain with candida species. All 36 family members were enrolled in the study, and 22 had blood samples taken for DNA analysis. Homozygosity mapping was used to locate the mutated gene. In the 4 affected family members (patients) and the 18 unaffected members we sequenced CARD9, the gene encoding the caspase recruitment domain-containing protein 9, carried out T-cell phenotyping, and performed functional studies, with the use of either leukocytes from the patients or a reconstituted murine model of the genetic defect. RESULTS: We found linkage (lod score, 3.6) to a genomic interval on chromosome 9q, including CARD9. All four patients had a homozygous point mutation in CARD9, resulting in a premature termination codon (Q295X). Healthy family members had wild-type expression of the CARD9 protein; the four patients lacked wild-type expression, which was associated with low numbers of Th17 cells (helper T cells producing interleukin-17). Functional studies based on genetic reconstitution of myeloid cells from Card9(-/-) mice showed that the Q295X mutation impairs innate signaling from the antifungal pattern-recognition receptor dectin-1. CONCLUSIONS: An autosomal recessive form of susceptibility to chronic mucocutaneous candidiasis is associated with homozygous mutations in CARD9. 2009 Massachusetts Medical Society

Author information

Author/s: Glocker, Erik-Oliver (EO); Hennigs, Andre (A); Nabavi, Mohammad (M); Schäffer, Alejandro A (AA); Woellner, Cristina (C); Salzer, Ulrich (U); Pfeifer, Dietmar (D); Veelken, Hendrik (H); Warnatz, Klaus (K); Tahami, Fariba (F); Jamal, Sarah (S); Manguiat, Annabelle (A); Rezaei, Nima (N); Amirzargar, Ali Akbar (AA); Plebani, Alessandro (A); Hannesschläger, Nicole (N); Gross, Olaf (O); Ruland, Jürgen (J); Grimbacher, Bodo (B);

Affiliation: Department of Immunology and Molecular Pathology, Royal Free Hospital and University College London, London, United Kingdom.

Journal and publication information

Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

Journal: The New England journal of medicine (N Engl J Med), published in United States. (Language: eng)

Reference: 2009-Oct; vol 361 (issue 18) : pp 1727-35

Dates: Created 2009/10/29; Completed 2009/11/04;

PMID: 19864672, status: MEDLINE (last retrieval date: 11/4/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

CommentIn: N Engl J Med. 2009 Oct 29;361(18):1798-801. (PMID: 19864679)

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.